Updated: April 16, 2026
Corporate VC
MRL Ventures Fund
Cambridge, USA
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Built with Episolo · Free to start
Need an MVP before applying?
Turn your startup idea into a working web app using AI. No coding required.
Updated: April 16, 2026
Alumni startups
30
Total investments
47
Successful exits
13
About the program
Program type
Investment stage
Description
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.
Location
Investment offer
Can lead rounds
Yes